Section of Rheumatology, Department of
Internal Medicine, Yale University School of Medicine, New Haven,
Connecticut 06520-8031
Received 8 October 1999/Returned for modification 9 December
1999/Accepted 22 December 1999
The cytokine response to the agent of human granulocytic
ehrlichiosis (HGE) was assessed in a murine infection model and the role of gamma interferon (IFN-
), a cytokine that is crucial for host
defenses against intracellular pathogens, was investigated by using
IFN-
-deficient mice. The agent of HGE (aoHGE) is an obligate
intracellular bacterium that survives within neutrophils: morulae
(vacuoles containing HGE organisms) are evident in polymorphonuclear leukocytes of experimentally infected immunocompetent mice for 1 to 2 weeks. We now show that IFN-
levels increase during early infection
of C3H/HeN or C57BL/6 mice with HGE bacteria. Moreover, in response to
aoHGE extracts or concanavalin A, splenocytes from ehrlichia-infected
mice produced more IFN-
and less interleukin-4 than controls,
suggesting that aoHGE partially skewed the immune response towards a
Th1 phenotype. Absolute concentration of morulae containing neutrophils
in blood was 122 ± 22 cells/µl on day 8. The bacterial DNA
burden was also highest on day 8 and then declined after IFN-
levels
peaked. In contrast, IFN-
-deficient mice had a markedly elevated HGE
bacteria burden with morulae concentration of 282 ± 48 cells/µl
on day 5 (P = 0.004) and 242 ± 63 cells/µl on
day 8 (P = 0.005). Rickettsemia resolved in
immunocompetent and IFN-
deficient mice after 2 weeks, while both
the immunocompetent and the IFN-
-deficient mice had increased serum
antibodies against aoHGE antigens at this time point. These data
demonstrate that the HGE agent elicits a prominent IFN-
response in
mice and that IFN-
is important in controlling the degree of
rickettsemia during the early phase of infection, while IFN-
independent mechanisms play a role at later time points.
 |
INTRODUCTION |
Human granulocytic ehrlichiosis
(HGE) is a tick-borne disease caused by an obligate intracellular
gram-negative organism that persists in granulocytes (14).
HGE has recently been described in the United States and Europe and is
found in areas where Borrelia burgdorferi and Babesia
microti, pathogens transmitted by Ixodes scapularis or
Ixodes ricinus ticks, are prevalent (3, 8, 9, 15, 16,
30, 31, 33, 34, 43). Fever, malaise, headache, myalgia, and
leukopenia are common during infection. The illness is usually mild and
limited, but severe symptoms, such as carditis and demyelinating
polyneuropathy occasionally occur, and fatalities have been documented
(6, 7, 19, 24). Immunocompromised patients may be at
increased risk of developing disease (2, 4). Most patients
develop early humoral responses toward products of the HGE-44 gene
family and other antigens during infection (3, 5, 23).
Laboratory mice can be infected with the agent of HGE (aoHGE) and serve
as a model for studying granulocytic ehrlichiosis (20, 28,
40). aoHGE-infected C3H mice developed a transient bloodstream
infection, thereby somewhat resembling human disease (20,
40). In contrast, aoHGE infection within polymorphonuclear leukocytes (PMNs) persisted in SCID mice (20). The kinetics of rickettsemia vary somewhat among the studies: the peak rickettsemia generally occurs between days 6 to 10, and the bacteremia can persist
up to day 39 (20, 42). Differences in the onset and the
duration of rickettsemia may be due to variations in the mode of
inoculation (tick versus syringe challenge), the inoculum size, and the
virulence of the aoHGE isolate used (20, 40, 42). Immunocompetent mice also developed antibodies to several aoHGE antigens, including HGE-44, providing another similarity with human
infection (20, 40). In addition, C3H mice actively immunized with aoHGE lysates or passively immunized with anti-aoHGE sera were
protected against aoHGE challenge (40). The protective anti-aoHGE sera contained high-titer antibodies to the HGE-44 protein,
and a monoclonal antibody to a member of the HGE-44 family has also
been shown to afford partial protection to infection, suggesting that
this antigen is a target for host defenses (28, 40). These
results demonstrated that mice can be used to study granulocytic
ehrlichiosis and that the humoral response to aoHGE was important in
immunity to infection (40).
Cellular immune responses have a prominent role in the control and
outcome of many infections, particularly those caused by intracellular
pathogens. The HGE agent is unusual, however, because this bacterium
persists within neutrophils
a cell that only lives for several days.
The nature of the T-cell response and the role of cytokines in the
evolution of aoHGE infection are not known. T-helper (Th) 1 responses
are commonly associated with gamma interferon (IFN-
) and interleukin
12 (IL-12), while IL-4, IL-5, and IL-10 are related to Th2 responses
(1). In general, Th1 responses are important in the
eradication of intracellular organisms, while Th2 responses facilitate
the clearance of extracellular pathogens. This paradigm is not without
exception, and the progression and resolution of infection is often
complex and multifactorial (12, 18, 22, 37). We therefore
now investigated the role of the cytokine response to aoHGE during
granulocytic ehrlichiosis in mice.
 |
MATERIALS AND METHODS |
Bacterial strains and maintenance of aoHGE infection.
The
NCH-1 isolate of aoHGE, which was recovered from a patient with
granulocytic ehrlichiosis and has been shown to be infectious in mice,
was used throughout these studies (41). aoHGE was initially cultured in HL-60 cells (240-CCL; American Type Culture Collection, Manassas, Va.) grown in Iscove's modified Dulbecco (Gibco BRL/Life Technologies, Grand Island, N.Y.) medium supplemented with 20% fetal
calf serum at 37°C with 5% CO2 as described earlier
(23). Inbred SCID mice were used to further cultivate aoHGE
for subsequent inoculation into inbred immunocompetent C3H/HeN (C3H) or
C57BL/6 (B6) mice. The use of blood from syngenic SCID mice infected
with aoHGE prevents a potential inflammatory response to HL-60 cells during the murine studies. C3H-scid and B6-scid
mice were obtained from the Frederick Cancer Research Center
(Frederick, Md.) and challenged with aoHGE by the intraperitoneal
(i.p.) injection of 100 µl of aoHGE-infected HL-60 cells.
Infection of C3H, C3H-scid, IFN-
-deficient
(IFN-
/
), and B6 mice with aoHGE and collection of
specimens.
Six-week-old, female C3H mice were obtained from the
Frederick Cancer Research Center laboratories. Twenty-eight C3H mice were inoculated with aoHGE by i.p. injection of 100 µl of
aoHGE-containing blood from donor C3H-scid mice. As a
control, seven C3H mice were injected with blood from uninfected
C3H-scid mice in an identical fashion. Groups of four
infected mice and one control mouse were sacrificed on days 2, 5, 8, 15, 21, 30, and 45. Experiments were repeated five times. Spleen,
anticoagulant-treated peripheral blood, and sera were collected from
each mouse upon necropsy. Splenic RNA was extracted, and splenocytes
were used for in vitro stimulation experiments. Twenty-eight 6-week-old
male IFN-
/
and twenty-eight age-matched B6 mice from
the Jackson Laboratories (Bar Harbor, Maine) were inoculated by using
blood from donor B6-scid mice and then sacrificed in a
similar manner as the C3H mice. Bacterial infection was assessed by
determining the percentage of morulae containing cells among 200 granulocytes examined in each peripheral blood smear, followed by the
multiplication of morulae percentage by absolute neutrophil counts.
Slides were stained with Diff-Quick (Baxter Healthcare Corp., Miami,
Fla.) and examined for morulae by light microscopy. The inoculum donor mouse blood morula-containing cell concentrations were 168 ± 47 (mean ± the standard deviation [SD]) in any of the five sets of experiments for C3H mice and 158 ± 57 (mean ± SD) for two
sets of experiments in B6 mice. All mice were maintained in
barrier-filtered cages, received a standard laboratory diet, and were
given water ad libitum.
PCR amplification of aoHGE DNA.
Prior to extraction of blood
DNA with the QIAamp Tissue Kit (Qiagen, Inc. Valencia, Calif.) 100 µl
of anticoagulated peripheral blood was incubated with 900 µl of
erythrocyte lysis buffer (155 mM NH4Cl, 10 mM
KHCO3, 1 mM EDTA) at room temperature for 10 min. Pelleted
cells were suspended in 200 µl of phosphate-buffered saline (PBS), pH
7.2, and DNA was extracted with the QIAamp Tissue Kit according to the
manufacturer's instructions.
A semiquantitative competitive PCR was employed to determine the aoHGE
blood DNA concentrations in C3H mice (21). A 549-bp competitor DNA fragment carrying an unrelated internal 504-bp B. burgdorferi OspA insert with external aoHGE primers was a kind gift of A. de Silva. An increasing known amount of competitor DNA was
mixed with a series of tubes containing constant amounts of target
mouse blood DNA in a 50-µl PCR reaction mixture with specific primers
for aoHGE 16S ribosomal DNA (rDNA): bp 497 to 521 (5'-TGT AGG CGG CGG
TTC GGT AAG TTA AAG-3') and bp 747 to 727 (5'-GCA CTC ATC GTT TAC AGC
GTG-3') (32). PCR was performed by using the following
intervals: 1 min at 94°C, 1 min at 54°C, and 2 min at 72°C.
Amplified products were resolved in a 2% agarose gel and stained with
ethidium bromide. Since both the competitor and the target aoHGE DNA
competed for the same primers, the DNA amount in the two samples were
considered equal when the PCR band intensities of these two DNA
molecules were equivalent. Experiments were repeated twice for each
mouse sample, and the mean value of four mice in each group was recorded.
The differences in aoHGE DNA content of blood from different days of
infection was also assessed by comparison of the intensity of the DNA
band from different samples. For this purpose pooled DNA samples from
each group were initially subjected to PCR amplification by using
primers specific for the housekeeping gene, hypoxanthine-guanine phosphoribosyltransferase (HPRT) (control) for the purpose of equalizing the amount of DNA in different samples. Normalized DNA
samples were amplified with the above-described 16S aoHGE rDNA primers
by using the above-described PCR intervals. Appearances of PCR band
densities from different days were compared to assess the differences.
Experiments were repeated at least twice.
Measurement of cytokine mRNA levels using reverse transcriptase
PCR.
Murine total RNA was extracted by the guanidine
isothiocyanate-phenol-chloroform single step method using the
Stratagene (La Jolla, Calif.) RNA isolation kit. Five micrograms of RNA
was reverse transcribed by using random primers to obtain cDNA with a
Stratagene kit in a 50-µl reaction mixture. The cDNAs from individual
mice at each time point were pooled. HPRT primers were used to assess and normalize the cDNA concentrations among samples from the seven time
points. An equal amount of DNA was added to PCR reaction mixtures to
amplify IFN-
, IL-4, IL-12, and IL-10 cDNA by using specific primers
(35). PCR experiments were repeated three times to validate
the result.
Secretion of cytokines from cultured splenocytes.
Single
cell suspensions of splenocytes from aoHGE-infected and uninfected
(control) mice were prepared on days 2, 5, 8, and 15 of infection
following lysis of erythrocytes with lysis buffer. Cells prepared from
each mouse were suspended in 1 ml of Click's medium containing 10%
fetal calf serum, 100 U of penicillin per ml, 100 U of streptomycin per
ml, and 2 mM L-glutamine and incubated in 24-well tissue
culture plates at a density of 2 × 106 cells/ml. Five
micrograms of concanavalin A (ConA) and 100, 25, and 5 µg of
sonication supernatants per ml from aoHGE-containing HL-60 cells or
uninfected HL-60 cells (see below) were added to the wells as
stimulants. After 24 or 48 h of incubation at 37°C in 5%
CO2, culture supernatants were collected and kept at
70°C until testing in cytokine enzyme-linked immunosorbent assays (ELISAs).
Cultivation and harvesting of aoHGE from HL-60 cells.
One
liter of aoHGE-infected HL-60 cells was used to isolate the bacteria.
As a control, uninfected HL-60 cells were processed in an identical
fashion. To harvest extracellular aoHGE, cells were centrifuged at
300 × g for 10 min, and the supernatants were collected. Pellets were resuspended in PBS-glucose (0.02%) and sonicated (Branson Sonifier, Danbury, Conn.) four times for 5 s
each time to disrupt HL-60 cells and release the aoHGE. Unbroken HL-60
cells were pelleted by centrifugation at 300 × g for
10 min. Released aoHGE was collected after centrifugation of the supernatant at 3,000 × g for 15 min at 4°C. These
aoHGE and extracellular aoHGE collected from the culture supernatant
were pooled and treated by sonication for 3 min on ice. Unbroken cells
were pelleted by centrifugation at 1,200 × g for 10 min. Released aoHGE were collected by centrifugation at
15,000 × g at 4°C and kept at
20°C until use in
in vitro splenocyte assays.
Determination of cytokine levels in sera and culture
supernatants.
Sera from animals in each group were pooled, and
then the IFN-
levels were assessed in sandwich ELISAs. In
vitro-stimulated splenocyte culture supernatants from individual mice
were also assayed for IFN-
and IL-4 levels. A total of 100 µl of
murine IFN-
or IL-4 (Pharmingen, San Diego, Calif.) antibodies,
suspended at a concentration of 200 ng/well in 0.1 mM
NaHCO2
(pH 9.6) were coated onto 96-well
plates (Nalge Nunc International) and incubated overnight at 4°C.
Nonspecific binding sites in each well were blocked by incubating with
200 µl of 1.5% bovine serum albumin in PBS (blocking buffer).
Serially diluted culture supernatants or sera were applied in wells
coated with the cytokine antibodies and incubated at room temperature
for 4 h. A total of 100 µl of purified cytokines (Pharmingen),
diluted in blocking buffer containing 0.05% Tween 20, was also added
at twofold serial dilutions to develop a standard curve. Wells were
washed with 0.05% Tween 20 in PBS. Then, 100 µl of biotinylated
antibodies (Pharmingen), diluted 1:4,000 in blocking buffer containing
0.05% Tween 20, was added to the wells and incubated for 45 min at
room temperature. Bound biotin was detected with peroxidase-conjugated
streptavidin (Bio-Rad Laboratories, Hercules, Calif.) used at a 1:500
dilution. A chromogenic reaction of peroxidase was developed with
3,3',5,5'-tetramethylbenzidine (Kirkegaard and Perry Laboratories,
Gaithersburg, Md.), and the absorbancy was read at 450 nm following the
addition of stop solution (Kirkegaard and Perry).
Serum anti-aoHGE ELISA.
Serum immunoglobulin G (IgG)
antibodies to aoHGE antigens in aoHGE-infected C3H,
IFN-
/
, and B6 mice were measured in ELISAs. Wells
were coated with 100 ng of aoHGE antigen per well as described above.
After the blocking step, serially diluted sera from the designated days of infection were added to wells. A hyperimmune mouse serum containing aoHGE antibodies was also added to each plate in serial dilutions to
correct plate-to-plate variations. Sera pooled from uninfected mice
C3H, IFN-
/
, and B6 mice were used as a negative
control. Plates with added sera were incubated at room temperature for
4 h. Wells were washed with washing buffer, and goat anti-mouse
IgG antibodies (Sigma) diluted 1:4,000 in 0.05% Tween 20 containing
blocking buffer were added. After 1-h incubation and washing steps,
development of chromogenic reaction and the reading of plates were done
as described above.
Statistics.
Differences between experimental groups were
analyzed by the Student's t test. The means ± the SD
were calculated, and a P value of <0.05 was considered significant.
 |
RESULTS |
Progression of granulocytic ehrlichiosis in C3H mice.
The
course of aoHGE infection in C3H mice was examined over a period of 45 days so that the progression of ehrlichiosis could then be correlated
with the cytokine responses. Infected neutrophil concentration and
bacteria DNA burden were assessed as indices of infection. Morulae were
evident 2 days after challenge, and the concentration of morulae
containing neutrophils increased until day 8, when 122 ± 22 cells/µl of the neutrophils had detectable morulae (Fig.
1). At later time points morulae were not
evident, except in one animal on day 15. The aoHGE burden in C3H mice
was also evaluated by a semiquantitative competitive PCR (Fig.
2A). aoHGE DNA was readily present in
blood on day 2, and the mean value of 4 mice was 3.05 ± 1.16 pg/ml (Fig. 2B). DNA concentrations measured on days 5 and 8 were
7.81 ± 3.0 and 11.0 ± 5.4 pg/ml, respectively. The level of
aoHGE DNA had the lowest values on day 15 (0.51 ± 0.13 pg/ml) and
was not detectable from days 21 to 45. In another approach, pooled DNA
samples from each group were amplified with 16S rDNA aoHGE primers
after normalizing the total DNA for the housekeeping gene HPRT in each
sample (Fig. 2C). Comparison of DNA band intensity appearances of each
group revealed that the rickettsemia peaked on days 5 to 8, followed by
a significant decrease on day 15. aoHGE DNA was not detected after day
15. The infection kinetics were similar with both methods. Therefore,
in subsequent studies, the intensity of the amplified products were
compared since this method is considerably less laborious than
semiquantitative competitive PCR when handling big sample sizes.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
The concentration of morula-containing neutrophils in
the bloodstream of C3H mice up to 45 days after challenge. Results
represent the mean ± the SD of four mice from each time point.
This set of animals were infected with 100 µl of SCID mouse blood
containing 195 cells of aoHGE infected neutrophils per µl. *, Not
detected.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
PCR analysis to determine the blood aoHGE DNA levels.
(A) Representative semiquantitative competitive PCR analysis. Mouse
blood DNA and a competitor DNA with primers specific for aoHGE 16S rDNA
was added to the PCR reaction mixture to allow competition for the
primers. Reaction tubes containing decreasing amounts of competitor DNA
facilitated comparison of sample DNA and the competitor DNA. When the
ratio of these two DNA bands was 1:1, they were considered equivalent,
and the sample DNA concentration was equal to the competitor
concentration. (B) DNA levels at different time points after infection
with semiquantitative competitive PCR. Starting from day 2, aoHGE DNA
concentrations increased until day 8. On day 15, aoHGE DNA levels were
significantly decreased. *, difference in values of day 8 and day 5 are statistically insignificant (P = 0.14); **,
difference in values of day 5 and day 2 are statistically significant
(P = 0.001). (C) PCR analysis of blood DNA samples
pooled among groups from different time points that were simultaneously
amplified following an initial DNA normalization step with HPRT-based
PCR.
|
|
Cytokine responses in C3H mice during aoHGE infection.
Comparative cytokine mRNA levels were determined in splenocytes of C3H
mice during aoHGE infection, and culture supernatant cytokine levels
were measured in in vitro stimulation assays by using splenocytes from
infected C3H mice. Sera pooled among each group were also screened for
IFN-
levels. IFN-
and IL-12 levels, which generally reflect Th1
responses, and IL-4 and IL-10, which are associated with Th2 responses
were assessed in vivo, and IFN-
and IL-4 levels were measured in
vitro. In the splenocytes of C3H mice, IFN-
mRNA was readily
detected on days 2 through 30 (Fig. 3A).
The PCR band intensity of IFN-
mRNA showed a decrease toward day 45. IL-12 mRNA was evident through day 8. IL-4 mRNA PCR bands were faintly
detected on day 5 and persisted through day 45, and IL-10 was detected
at most intervals.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Splenic cytokine mRNA levels in C3H mice during
infection with aoHGE. cDNA levels of each sample were normalized by
using HPRT primers. (B) Serum IFN- concentrations measured in
sandwich ELISAs. Sera of animals from each time point were pooled and
applied to wells as undiluted. Means of triplicate samples are
recorded. *, P = 0.02 compared to uninfected mice;
**, P = 0.04 compared to day 2 values.
|
|
Pooled sera from groups of four mice were subjected to ELISA test to
measure the serum IFN-
levels. IFN-
levels were significantly higher (P = 0.02) than control mice on day 2 of
infection (Fig. 3B) and peaked on day 8, followed by a gradual decrease
on the remaining days. Serum IFN-
levels reflected the mRNA levels
with the exception of day 2. The PCR band intensities were similar on
days 2 and 5, while day 2 serum levels were significantly less than
those of day 5 (P = 0.04). This variance during the
early stage of infection could be due to temporal differences between mRNA transcription and protein expression.
Stimulation assays with single-cell splenocyte suspensions at 2, 5, 8, and 15 days revealed increased IFN-
levels. The highest level of
IFN-
was detected on day 8 after aoHGE challenge (Fig. 4A). Splenocytes from infected C3H mice
produced 1.36 ± 0.14 ng of IFN-
per ml when incubated with 100 µg of aoHGE extract per ml, while cells from control (uninfected)
mice did not produce IFN-
(P = 0.002). The increase
in IFN-
production was dose dependent. Cells from infected animals
also had significantly higher IFN-
levels (P = 0.002) when incubated with aoHGE extract than with HL-60 extract
(control), demonstrating that the increased secretion of IFN-
was
not due to components of HL-60 cells that could have been retained
during aoHGE purification. ConA also induced higher IFN-
levels in
aoHGE-infected splenocytes than in uninfected splenocytes (P < 0.002) and, conversely, higher levels of IL-4 secretion
(P < 0.01) in splenocytes from uninfected mice
(controls) than from splenocytes from aoHGE-infected mice (Fig. 4B).
These responses to ConA suggest that aoHGE infection skewed the immune response toward a Th1 phenotype. aoHGE and HL-60 cell extracts did not
stimulate detectable IL-4 in infected or uninfected mouse splenocyte
cultures (Fig. 4B).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Levels of IFN- (A) and IL-4 (B) in stimulation assays
with splenocytes from aoHGE-infected C3H mice (8 days). Splenocytes
were incubated with 5 µg of ConA per ml and 100, 25, or 5 µg of
sonication supernatants of aoHGE per ml containing HL-60 cells or HL-60
cells alone. IFN- levels were measured at 48 h, and IL-4 levels
were measured at 24 h. All values are the means ± the SD of
four mice. *, P < 0.002 compared to uninfected mice;
**, P = 0.001 compared to HL-60 extract stimulated
splenocytes; ***, P < 0.01 compared to infected
mice. , Uninfected mice; , infected mice.
|
|
aoHGE infection and cytokine profile in IFN-
/
and B6 mice.
These data imply that IFN-
is a prominent cytokine
during murine infection with aoHGE and that bacterial levels decrease after IFN-
become evident. IFN-
/
mice were then
used to further explore the importance of IFN-
in the course of
aoHGE infection. Groups of IFN-
/
and the wild-type
B6 (control) mice were assessed for ehrlichiosis on days 2, 5, 8, 15, 21, 30, and 45. The concentration of morulae containing neutrophils was
markedly higher in the IFN-
/
mice than in control
animals (51 ± 21 cells/µl) on days 2, 5, and 8, reaching levels
of 282 ± 48 cells/µl (P = 0.004) (Fig. 5A). In addition, PCR revealed more aoHGE
DNA in IFN-
/
than in control animals (Fig. 5B).
Morulae were not detectable after day 8 and Ehrlichia DNA
was not evident after day 15 in both IFN-
/
and B6
mice.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
aoHGE infection in IFN- / and B/6 mice
up to 45 days after challenge with ehrlichiae. (A) Morulae containing
neutrophil concentrations in the bloodstream. Means ± the SD are
derived from three mice examined at each time point. This set of
animals were infected with 100 µl of SCID mice blood containing 198.4 cells/µl of aoHGE infected neutrophils. *, Not detected; **,
P = 0.004 compared to B6 mice; ***, P = 0.005 compared to B6 mice. (B) Blood aoHGE DNA levels, amplified
by using 16S DNA primers. DNA levels of each sample were normalized by
using HPRT (not shown).
|
|
aoHGE-infected B6 mice had persistently detectable IFN-
mRNA, which
were most prominent on days 5, 8, and 15 (Fig.
6) and, as expected,
IFN-
/
mice did not produce any IFN-
. IL-4 mRNA
PCR band intensities were greater in the IFN-
/
mice
than in the wild-type B6 mice (Fig. 6). There was no significant difference in IL-10 and IL-12 mRNA PCR band intensities between the
IFN-
/
and the control mice.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 6.
Spleen cytokine mRNA levels of aoHGE-infected
IFN- / and B6 mice after various intervals after
aoHGE challenge. cDNA levels of each sample were normalized by using
HPRT primers.
|
|
Splenocytes from infected B6 mice produced 1.0 ± 0.1 ng of
IFN-
per ml when incubated with 100 µg of aoHGE extract per ml, whereas uninfected mice did not produce IFN-
(Fig.
7A). IL-4 was not detected in infected
mice stimulated with aoHGE extract. In contrast, ConA induced much
stronger IL-4 responses in splenocytes from uninfected mice (Fig. 7B).
IFN-
levels were slightly higher when splenocytes from infected,
rather that uninfected, mice were stimulated with ConA.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 7.
Levels of IFN- (A) and IL-4 (B) in stimulation assays
with splenocytes from aoHGE-infected B6 mice (8 days). Splenocytes were
incubated with 5 µg of ConA per ml and 100 µg of sonication
supernatants of aoHGE per ml containing HL-60 cells or HL-60 cells
alone. IFN- levels were measured at 48 h, and IL-4 levels were
measured at 24 h. All values are the means ± the SD of four
mice. , Uninfected mice; , infected mice.
|
|
Antibody response to aoHGE in C3H, IFN-
/
, and B6
mice.
Serum IgG antibodies to aoHGE antigens manifested a
significant increase in IFN-
/
(P = 0.01), and B6 (P = 0.02) mice on day 8 compared to
uninfected mice, while C3H mice had increased antibody levels
(P = 0.001) only on day 15 (Fig.
8). On day 15 all three mice had
comparable antibody levels to aoHGE. The increase in antibodies to
aoHGE continued in all mice until day 30 and then stayed at the same level on day 45.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 8.
Development of anti-aoHGE IgG antibodies in the sera of
C3H, IFN- / , and B6 mice. Sera were pooled among four
animals from each time point. All values are the means ± the SD
of three experiments.
|
|
 |
DISCUSSION |
These studies investigated the role of IFN-
in the development
of murine aoHGE infection. It was first demonstrated that IFN-
is a
dominant cytokine during the early phase of granulocytic ehrlichiosis
in immunocompetent C3H and B6 mice. In addition, morulae were prominent
on day 8 and then cleared from the bloodstream when IFN-
were at
their highest level. The aoHGE bacterial burden, as assessed by PCR,
followed a similar course. These results suggest that IFN-
may
facilitate bacterial clearance. To explore this hypothesis in greater
detail, we assessed the course of infection in IFN-
/
mice. The IFN-
/
mice had markedly increased
concentrations of infected neutrophils at day 5 (282 ± 48 cells/µl) and elevated levels of aoHGE DNA, further suggesting that
this cytokine plays a role in controlling the degree of rickettsemia
during the early phase of infection. Although ehrlichiosis was more
prominent at 8 days in the IFN-
/
mice than in the
control mice, both groups of animals cleared aoHGE from the bloodstream
at 2 to 3 weeks. This suggests that IFN-
-independent mechanisms such
as humoral immunity and cellular responses may play an important role
in the control of the pathogen at these later time points. Indeed,
immunocompetent and IFN-
/
mice had IgG antibodies to
aoHGE that were readily detectable after 8 to 15 days of infection.
For several years, mice have been used as an experimental model for
aoHGE infection (20, 21, 40, 42). The kinetics of infection,
including the peak of aoHGE infection and the duration of rickettsemia,
varies somewhat among the studies, although all of the studies suggest
a peak infection during the first several weeks with subsequent
bacterial clearance. Differences in the results may be attributed to
the dosage of inoculum, the mode of inoculum (tick or syringe
challenge), or the virulence of the inoculated bacteria. The course of
rickettsemia is shorter in the current study (15 days) than in our
earlier report (30 days) (21). This difference may be
attributed to the smaller inoculum size used in this study compared to
the earlier study (ca. 7% versus 17 to 20% percentage of morulae).
The data obtained in this study also show that aoHGE infection skews
the immune response toward a Th1 phenotype. Upon stimulation with aoHGE
extract or ConA, splenocytes from aoHGE-infected C3H or B6 mice both
showed a markedly elevated level of IFN-
compared with splenocytes
from uninfected mice (controls). Furthermore, the IL-4 levels were
lower when infected, rather than uninfected, cells were stimulated with
ConA. aoHGE antigens may therefore predominantly induce a Th1 response
during the early stage of infection. Indeed, leishmaniae, which survive
within macrophages, have been shown to express specific antigens which
direct the immune response toward a Th1 or a Th2 response (26, 38,
39). Moreover, transgenic mice that are tolerant to LACK, a
leishmania antigen that promotes Th2 responses, become resistant to
infection (26). Identification of the aoHGE antigens that
are involved in initiating a Th1 response may aid our understanding of
the bacterial factors that influence the host response and the course of infection.
The IFN-
response to aoHGE may lead to a number of effects that may
affect infection. Natural killer (NK) cells and T lymphocytes are two
known sources of IFN-
(1, 36). Since IFN-
was evident in aoHGE-infected SCID mice, it is likely that NK cells contribute to
IFN-
production. IFN-
can induce nitric oxide synthesis by phagocytic cells, and this may facilitate pathogen clearance (10, 25, 27): increased mortality in mycobacterium-infected
IFN-
/
mice has been associated with abolished nitric
oxide activity and altered major histocompatibility complex (MHC) II
expression (13). Furthermore, IFN-
-induced MHC II
expression of macrophages can be downregulated by Toxoplasma
gondii (29). Cytokines such as IL-4, which elicit Th2
response, may alter some of the effects exerted by IFN-
. Th2
responses can lead to downregulation of nitric oxide production by
macrophages (11), and IL-10 blocks the IFN-
-dependent
microbicidal effect of macrophages on T. gondii and the
extracellular killing of Schistosoma mansoni
(17). Our study showed that murine aoHGE infection induces
the production of IL-10 and, to a lesser degree, of IL-4 following the
initial IFN-
burst. The inhibitory activities of these two cytokines could contribute to the persistence of aoHGE.
The immunologic parameters that influence the progression of
granulocytic ehrlichiosis are likely to be multifactorial. Most intracellular pathogens which are used to study cellular immune responses persist in macrophages (such as leishmaniae) or epithelial cells (such as listeriae). The HGE agent is unusual in that it persists
with PMNs: a cell that only survives for several days. These studies
show that IFN-
plays a role in controlling the degree of early
rickettsemia and aoHGE infection when antibodies are not yet readily
available. The murine model of granulocytic ehrlichiosis will enable us
to dissect the cytokine responses to aoHGE and the mechanisms by which
these cytokines act to facilitate the clearance of this pathogen within
neutrophils during different stages of infection.
We thank Deborah Beck for technical assistance and Juan Anguita
for critical reading of the manuscript.
This work was supported by NIH grant AI41440. M.A. was supported by the
Brown-Coxe postdoctoral fellowship program at Yale, and E.F. is a
recipient of a Clinical Scientist Award in Translational Research from
the Burroughs Wellcome Fund.
| 1.
|
Abbas, A.,
K. M. Murphy, and A. Sher.
1996.
Functional diversity of helper T lymphocytes.
Nature
383:787-793[CrossRef][Medline].
|
| 2.
|
Adachi, J. A.,
E. M. Grimm,
P. Johnson,
M. Uthman,
B. Kaplan, and R. M. Rakita.
1997.
Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature.
Transplantation
64:1139-1142[CrossRef][Medline].
|
| 3.
|
Aguero-Rosenfeld, M. E.,
H. W. Horowitz,
G. P. Wormser,
D. F. McKenna,
J. Nowakowski,
J. Munoz, and J. S. Dumler.
1996.
Human granulocytic ehrlichiosis: a case series from a medical center in New York State.
Ann. Intern. Med.
125:904-908[Abstract/Free Full Text].
|
| 4.
|
Anthony, S. J.,
J. S. Dumler, and E. Hunter.
1995.
Human ehrlichiosis in a liver transplant recipient.
Transplantation
60:879[Medline].
|
| 5.
|
Bakken, J. S.,
J. Krueth,
C. Wilson-Nordskog,
R. L. Tilden,
K. Asanovich, and J. S. Dumler.
1996.
Clinical and laboratory characteristics of human granulocytic ehrlichiosis.
JAMA
275:199-205[Abstract].
|
| 6.
|
Bakken, J. S.,
S. A. Erlenmeyer,
R. J. Kanoff,
T. C. Silvesterini II,
D. D. Goodwin, and J. S. Dumler.
1998.
Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis.
Clin. Infect. Dis.
27:1323-1324[Medline].
|
| 7.
|
Bakken, J. S.,
J. S. Dumler,
S. M. Chen,
M. R. Eckman,
L. L. Van Etta, and D. H. Walker.
1994.
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?
JAMA
272:212-218[Abstract].
|
| 8.
|
Bakken, J. S.,
J. Krueth,
R. L. Tilden,
J. S. Dumler, and B. E. Kristiansen.
1996.
Serological evidence of human granulocytic ehrlichiosis in Norway.
Eur. J. Clin. Microbiol. Infect. Dis.
15:829-832[CrossRef][Medline].
|
| 9.
|
Bakken, J. S.,
P. Goellner,
M. van Etten,
D. Z. Boyle,
O. L. Swonger,
S. Mattson,
J. K. Krueth,
R. L. Tilden,
K. Asanovich,
J. Walls, and J. S. Dumler.
1998.
Seroprevalance of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin.
Clin. Infect. Dis.
27:1491-1496[Medline].
|
| 10.
|
Beckerman, K. P.,
H. W. Rogers,
J. A. Corbett,
R. D. Schreiber,
M. L. McDaniel, and E. R. Unanue.
1993.
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.
J. Immunol.
150:888-895[Abstract].
|
| 11.
|
Bogdan, C.,
Y. Vodovotz,
J. Paik,
Q. Xie, and C. Nathan.
1994.
Mechanisms of suppression of NOS expression by IL-4 in primary mouse macrophages.
J. Leukoc. Biol.
55:227-233[Abstract].
|
| 12.
|
Brunet, L. R.,
D. W. Dunne, and E. J. Pearce.
1998.
Cytokine interaction and immune responses during Schistosoma mansoni infection.
Parasitol. Today
14:422-427.
|
| 13.
|
Dalton, D. K.,
S. Pitts-Meek,
S. Keshav,
S. I. Figari,
A. Bradley, and T. A. Steward.
1993.
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science
259:1739-1742[Abstract/Free Full Text].
|
| 14.
|
Dumler, J. S., and J. S. Bakken.
1998.
Human ehrlichiosis: newly recognized infections transmitted by ticks.
Annu. Rev. Med.
49:201-213[CrossRef][Medline].
|
| 15.
|
Dumler, J. S., and J. S. Bakken.
1996.
Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence.
J. Infect. Dis.
173:1027-1030[Medline].
|
| 16.
|
Fingerle, V.,
J. L. Goodman,
R. C. Johnson,
T. J. Kurtti,
U. G. Munderloh, and B. Wilske.
1997.
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups.
J. Clin. Microbiol.
35:3244-3247[Abstract].
|
| 17.
|
Gazinelli, R. T.,
I. P. Oswald,
S. L. James, and A. Sher.
1992.
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
J. Immunol.
148:1792[Abstract].
|
| 18.
|
Gazinelli, R. T.,
M. Wysocka,
S. Hieny,
T. Scharton-Kersten,
A. Cheever,
R. Kuhn,
W. Muller,
G. Trinchieri, and A. Sher.
1996.
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
J. Immunol.
157:798-805[Abstract].
|
| 19.
|
Hardalo, C. J.,
V. Quagliarello, and J. S. Dumler.
1996.
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case.
Clin. Infect. Dis.
21:910-914.
|
| 20.
|
Hodzic, E.,
J. W. Ijdo,
S. Feng,
P. Katavalos,
W. Sun,
C. H. Maretzki,
D. Fish,
E. Fikrig,
S. R. Telford III, and S. W. Barthold.
1998.
Granulocytic ehrlichiosis in the laboratory mouse.
J. Infect. Dis.
177:737-745[Medline].
|
| 21.
|
Hodzic, E.,
D. Fish,
C. M. Maretzki,
A. M. De Silva,
S. Feng, and S. W. Barthold.
1998.
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks.
J. Clin. Microbiol.
36:3574-3578[Abstract/Free Full Text].
|
| 22.
|
Hunter, C. A.,
L. A. Ellis-Neyes,
T. Slifer,
S. Kanaly,
G. Grunig,
M. Fort,
D. Rennick, and F. G. Araujo.
1997.
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.
J. Immunol.
158:3311-3316[Abstract].
|
| 23.
|
Ijdo, W. J.,
W. Sun,
Y. Zhang,
L. A. Magnarelli, and E. Fikrig.
1998.
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.
Infect. Immun.
66:3264-3269[Abstract/Free Full Text].
|
| 24.
|
Jahangir, A.,
C. Kolbert,
W. Edwards,
P. Mitchell,
J. S. Dumler, and D. H. Persing.
1998.
Fatal pancarditis associated with human granulocytic ehrlichiosis in 44-year-old man.
Clin. Infect. Dis.
27:1424-1427[Medline].
|
| 25.
|
James, S. L., and J. Glaven.
1989.
Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.
J. Immunol.
143:4808-4812.
|
| 26.
|
Julia, V.,
M. Rassoulzadegan, and N. Glaichenhaus.
1996.
Resistance to Leishmania major induced by tolerance to a single antigen.
Science
274:421-423[Abstract/Free Full Text].
|
| 27.
|
Karupiah, G.,
Q. W. Xie,
R. M. Buller,
C. Nathan,
C. Duarte, and J. D. MacMicking.
1993.
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.
Science
261:1445-1448[Abstract/Free Full Text].
|
| 28.
|
Kim, H. Y., and Y. Rikihisa.
1998.
Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.
J. Clin. Microbiol.
36:3278-3284[Abstract/Free Full Text].
|
| 29.
|
Luder, C. G.,
T. Lang,
B. Beuerle, and U. Gross.
1998.
Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii.
Clin. Exp. Immunol.
112:308-316[CrossRef][Medline].
|
| 30.
|
Magnarelli, L. A.,
J. W. Ijdo,
J. Anderson,
S. J. Padula,
R. A. Flavell, and E. Fikrig.
1998.
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut.
J. Clin. Microbiol.
36:2823-2827[Abstract/Free Full Text].
|
| 31.
|
Nadelman, R. B.,
H. W. Horowitz,
T. C. Hsieh,
J. M. Wu,
M. E. Aguero-Rosenfeld,
I. Schwartz,
J. Nowakowski,
S. Varde, and G. P. Wormser.
1997.
Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis.
N. Engl. J. Med.
337:27-30[Free Full Text].
|
| 32.
|
Pancoli, P.,
C. P. Kolbert,
P. D. Mitchell,
K. D. Reed, Jr.,
J. S. Dumler,
J. S. Bakken,
S. R. Telford, and D. H. Persing.
1995.
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.
J. Infect. Dis.
172:1007-1012[Medline].
|
| 33.
|
Petrovec, M.,
S. L. Furlan,
T. A. Zupanc,
F. Strle,
P. Brouqui,
V. Roux, and J. S. Dumler.
1997.
Human disease in Europe caused by a granulocytic Ehrlichia species.
J. Clin. Microbiol.
35:1556-1559[Abstract].
|
| 34.
|
Pusterla, N.,
R. Weber,
C. Wolfensberger,
G. Schar,
R. Zbinden,
W. Fierz,
J. E. Madigan,
J. S. Dumler, and H. Lutz.
1998.
Serological evidence of human granulocytic ehrlichiosis in Switzerland.
Eur. J. Clin. Microbiol. Infect. Dis.
17:207-209[Medline].
|
| 35.
|
Reiner, S. L.,
S. Zheng,
D. B. Corry, and R. M. Locksley.
1993.
Constructing polycompetitor cDNAs for quantitative PCR.
J. Immunol. Methods
165:37-46[CrossRef][Medline].
|
| 36.
|
Scharton, T. M., and P. Scott.
1993.
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
J. Exp. Med.
178:567-577[Abstract/Free Full Text].
|
| 37.
|
Scott, P.
1991.
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
J. Immunol.
147:3149-3155[Abstract].
|
| 38.
|
Skeiky, Y. A.,
M. Kennedy,
D. Kaufman,
M. M. Borges,
J. A. Guderian,
J. K. Scholler,
P. J. Ovendale,
K. S. Picha,
P. J. Morrissey,
K. H. Grabstein,
A. Campos-Neto, and S. G. Reed.
1998.
LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
J. Immunol.
11:6171-6179.
|
| 39.
|
Skeiky, Y. A.,
J. A. Guderian,
D. R. Benson,
O. Bacelar,
E. M. Carvalho,
M. Kubin,
R. Badaro,
G. Trinchieri, and S. G. Reed.
1995.
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
J. Exp. Med.
181:1527-1537[Abstract/Free Full Text].
|
| 40.
|
Sun, W.,
J. W. Ijdo,
S. R. Telford III,
E. Hodzic,
Y. Zhang,
S. W. Barthold, and E. Fikrig.
1997.
Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
J. Clin. Investig.
100:3014-3018[Medline].
|
| 41.
|
Telford, I. S. R.,
T. J. Lepore,
P. Snow,
C. K. Warner, and J. E. Dawson.
1995.
Human granulocytic ehrlichiosis in Massachusetts.
N. Engl. J. Med.
334:209-215[Abstract/Free Full Text].
|
| 42.
|
Telford, S. R., III,
J. E. Dawson,
P. Katavolos,
C. K. Warner,
C. P. Kolbert, and D. H. Persing.
1996.
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
Proc. Natl. Acad. Sci. USA
93:6209-6214[Abstract/Free Full Text].
|
| 43.
|
Wallace, B. J.,
G. Brady,
D. M. Ackman,
S. J. Wong,
G. Jacquette,
E. E. Lloyd, and G. S. Birkhead.
1998.
Human granulocytic ehrlichiosis in New York.
Arch. Intern. Med.
158:769-773[Abstract/Free Full Text].
|